A theme in which orders and revenue in the pharmaceutical field fall below the year-earlier level due to a reactionary decline in temporary spot projects related to new drug application materials. Even when large projects are won or orders are received from other customers, the reactionary decline in spot projects becomes a short-term factor reducing revenue.